Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Maresca

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Diabetes|December 29, 2022
Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin SignalingHenrik Palmgren, Kasparas Petkevicius, Stefano Bartesaghi, et al.
BMC Biology|January 17, 2019
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse modelAlba Carreras, Luna Simona Pane, Roberto Nitsch, et al.
Molecular Brain|May 6, 2020
Axl receptor tyrosine kinase is a regulator of apolipoprotein EWenchen Zhao, Jianjia Fan, Iva Kulic, et al.
Stem Cell Research|May 8, 2018
NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populationsShailesh Kumar Gupta, Agata Wesolowska-Andersen, Anna K Ringgaard, et al.
Nature Communications|January 22, 2021
Universal toxin-based selection for precise genome engineering in human cellsSongyuan Li, Nina Akrap, Silvia Cerboni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytesMihaela Zabulica, Raghuraman C Srinivasan, Pinar Akcakaya, et al.
Nature Communications|November 3, 2025
Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCRNathan White, John Alexander Chalk, Yi-Ting Hu, et al.
Nature|September 14, 2018
In vivo CRISPR editing with no detectable genome-wide off-target mutationsPinar Akcakaya, Maggie L Bobbin, Jimmy A Guo, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Communications|September 6, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivoBurcu Bestas, Sandra Wimberger, Dmitrii Degtev, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Diabetes|December 29, 2022
Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin SignalingHenrik Palmgren, Kasparas Petkevicius, Stefano Bartesaghi, et al.
BMC Biology|January 17, 2019
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse modelAlba Carreras, Luna Simona Pane, Roberto Nitsch, et al.
Molecular Brain|May 6, 2020
Axl receptor tyrosine kinase is a regulator of apolipoprotein EWenchen Zhao, Jianjia Fan, Iva Kulic, et al.
Stem Cell Research|May 8, 2018
NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populationsShailesh Kumar Gupta, Agata Wesolowska-Andersen, Anna K Ringgaard, et al.
Nature Communications|January 22, 2021
Universal toxin-based selection for precise genome engineering in human cellsSongyuan Li, Nina Akrap, Silvia Cerboni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytesMihaela Zabulica, Raghuraman C Srinivasan, Pinar Akcakaya, et al.
Nature Communications|November 3, 2025
Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCRNathan White, John Alexander Chalk, Yi-Ting Hu, et al.
Nature|September 14, 2018
In vivo CRISPR editing with no detectable genome-wide off-target mutationsPinar Akcakaya, Maggie L Bobbin, Jimmy A Guo, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Communications|September 6, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivoBurcu Bestas, Sandra Wimberger, Dmitrii Degtev, et al.
Pageof 5